I-BODY
LIVE

Serial Number

79368363

Owner

AdAlta Limited

Attorney

Cheryl L. Burbach

Filing Date

Apr 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

I-BODY Trademark

Serial Number: 79368363

I-BODY is a trademark filed by AdAlta Limited on April 4, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

AdAlta Limited

15/2 Park Drive

Entity Type: 99

Trademark Details

Filing Date

April 4, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, biological preparations for the treatment of fibrosis, cancer and other diseases; Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, prescription injectable pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, prescription injectable biological preparations for the treatment of fibrosis, cancer and other diseases, inhaled pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, inhaled biological preparations for the treatment of fibrosis, cancer and other diseases; diagnostic preparations and reagents for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody fragments for combining with other chemicals, proteins and cells for medical or diagnostic purposes; antibody conjugates for medical purposes; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for medical research use in the development of monoclonal antibodies for medical purposes; molecular targets for drug and vaccine development, all in the nature of biological reagents for medical research use; tagged antibodies for medical research and medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes, namely, for capturing, imaging, detecting, identifying or characterising protein and cell therapeutic candidates; reagents for use in diagnostic tests for medical purposes; reagents for medical research applications for medical diagnosis; biological tissue, namely, recombinant human protein production cell line for medical use or modified human cells for therapeutic use; biological tissue, namely recombinant human protein production cell line for modified human cells for therapeutic use; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology for medical purposes

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2026 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 31, 2026 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 28, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 28, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 28, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 28, 2026 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 28, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 27, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 24, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 20, 2025 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 12, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 25, 2024 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 13, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 13, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 13, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 19, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 11, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 27, 2023 REPR